DeutschNewstral
Article
Seattle Times on 2024-05-24 16:29
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
Related news
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroStar Tribune
Eli Lilly Surges On Strong Earnings As Mounjaro And Zepbound Sales SoarForbes- MEli Lilly Zepbound, Mounjaro obtainable after shortages, FDA saysmvtelegraph.com
Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarterseattletimes.com- Mounjaro/Zepbound Drastically Cuts Risk Of Type 2 Diabetes, Eli Lilly Report SuggestsForbes
Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heightstimesfreepress.com- IEli Lilly announces $2.1 billion manufacturing expansion in Boone Countyindystar.com
- DEli Lilly slumps after disappointing Zepbound weight-loss-drug trialdcourier.com
- MEli Lilly sues clinics allegedly promoting knockoff variations of Mounjaromvtelegraph.com
- Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugsSeattle Times
- Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly SaysForbes
Eli Lilly launches website, home delivery option for Wegovy alternative ZepboundNew York Post
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly ReportsThe New York Times- Weight Loss Drug Zepbound Could Lower Heart Failure Risks, Eli Lilly SaysForbes
- NEli Lilly slashes price of weight-loss drug Zepbound by 50% to sell in smaller dosesnypost.com
- Eli Lilly Pushes For Fast-Track Approval Of Mounjaro As Weight-Loss DrugForbes
Eli Lilly sues businesses selling knockoff versions of Mounjaro - Tue, 19 Sep 2023 PSTsyndication.washingtonpost.com
Central NC home for new Eli Lilly manufacturing campusapnews.com